Illumina Ventures Announces Winners of Inaugural Irish Genomics Business Plan Competition
UCD’s NAX Bioscience and TCD’s Imragen recognised for novel genomics-driven technologies and commercial potential
News
listing-news
Latest News
Sonothera closes over-subscribed $125 million Series B financing to advance clinical development
Sonothera closes their Series B financing to advance clinical development of ultrasound mediated non-viral genetic medicines.
Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes
Collaboration seeks to accelerate translation and development of stem cell-derived pancreatic cells
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
Predicta Biosciences today announced the commercial expansion of a co-branded whole-genome sequencing (WGS) assay, currently known as GenoPredicta™, intended for the comprehensive genomic characterization of hematologic malignancies and measurable residual disease (MRD) monitoring.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
0 selected
Generating previews...